Home Medical Equipment Market (2026 - 2035)

Home Medical Equipment Market Research Report By Product Type (Monitoring Equipment, Therapeutic Equipment, Home Mobility Equipment, Daily Living Aids, Medical Supplies), By End User (Hospitals, Home Care, Nursing Homes, Rehabilitation Centers), By Application (Chronic Disease Management, Post-Surgical Care, Elderly Care, Disability Assistance), By Distribution Channel (Retail Stores, Online Stores, Direct Sales) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2026-2035
CAGR
6.65%
2025 Market Size
USD 54.20 Billion (2025)
2035 Market Size
USD 103.18 Billion (2035)
Medical Device ● Updated July 22, 2026 Report ID: MRFR/MED/7014-HCR | Pages: 100 | Author: Nidhi Mandole, Rahul Gotadki

Home Medical Equipment Market Summary

The Home Medical Equipment Market reached a valuation of USD 54.20 Billion in 2025 and is set to grow from USD 57.80 Billion in 2026 to USD 103.18 Billion by 2035, registering a CAGR of 6.65% across the forecast window. Two structural catalysts are accelerating this trajectory: the U.S. Centers for Medicare & Medicaid Services (CMS) expanded its home health coverage categories by 14% in 2024, and the WHO's 2023 Ageing & Health framework committed USD 1.3 billion in capacity-building grants for home-based chronic-disease management across 48 low- and middle-income countries [1][2]. These policy moves are pulling care delivery away from acute-care facilities and into the living room — a shift that directly lifts demand for therapeutic, diagnostic, and mobility devices designed for non-clinical settings.

The competitive blueprint in the Home Medical Equipment Market is being rewritten by technology transformation. Bluetooth- and cellular-connected alternatives that provide real-time vitals to physician dashboards are replacing legacy analog devices, including standalone glucometers, manual oxygen concentrators, and basic wheelchairs. The 2024 CONNECT Health Act, which was implemented by the U.S. Department of Health and Human Services, allocated USD 680 million to reimburse providers who incorporate connected home devices into care pathways. This initiative directly encourages manufacturers to incorporate sensors and wireless modules into next-generation equipment [3]. This connectivity pivot also enables recurring-revenue streams through software subscriptions and data analytics services, reshaping profit pools throughout the value chain.

In 2025, North America held approximately 40.35% of the Home Medical Equipment Market, which was primarily driven by a mature distribution network and a favorable private-payer mix. The Asia-Pacific region is the fastest-growing region, with a projected expansion rate of 9.45% CAGR through 2035. This growth is being driven by rapid urbanization, increasing out-of-pocket healthcare expenditure, and government digital-health programs in the economies of India, China, and ASEAN. The second-largest share was held by Europe at 26.15%, which was maintained by the aging demographics in Germany, France, and the Nordic region, as well as stringent but predictable MDR compliance standards. The Home Medical Equipment Market is poised for sustained growth in the coming decade as reimbursement policies, demographic shifts, and device innovation converge.

 

 

Key Report Takeaways

• By Functionality

  • Therapeutic equipment held a 48.50% revenue share of the Home Medical Equipment Market in 2025, underpinned by steady demand for respiratory therapy devices, infusion pumps, and dialysis systems used in home settings.
  • Mobility assist and patient support is the fastest-growing functionality segment, advancing at a 9.25% CAGR through 2035 as aging populations require walkers, powered wheelchairs, and patient lifts.

• By Distribution

  • Retail medical stores accounted for 42.65% of global revenue in 2025, though online retail channels are expanding at an 11.15% CAGR as e-commerce penetration deepens across all geographies.

 

• By Connectivity

  • Connected and smart devices are forecast to grow at a 10.55% CAGR between 2026 and 2035, gradually displacing conventional standalone products in the Home Medical Equipment Market.

• By Region

  • North America led the Home Medical Equipment Market with a 40.35% share in 2025, benefiting from robust Medicare reimbursement pathways and a well-established DME supplier network.
  • Asia-Pacific is projected to register the highest regional CAGR of 9.45% through 2035, fueled by government health digitization initiatives and expanding middle-class healthcare access.

 

Home Medical Equipment Market Size and Forecast (2021–2035)

Market Research Future's sizing model integrates top-down revenue analysis from public filings of leading manufacturers with bottom-up demand estimates derived from disease prevalence databases, reimbursement claim volumes, and distribution-channel sell-through data. Historical figures (2021–2024) are validated against customs trade statistics and industry association shipment reports; forecast projections apply segment-weighted CAGRs calibrated to macro-demographic and regulatory assumptions.

Home Medical Equipment Market Size and Forecast
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Driver Impact Analysis

Driver ~% Impact on CAGR Geographic Relevance Impact Timeline
Expanding Medicare & insurance reimbursement for home devices +1.30% North America Short-term (≤2 yr)
Global aging population and chronic-disease prevalence rise +1.45% Global Long-term (≥4 yr)
Smart-device connectivity and telehealth integration +0.95% North America, Europe Medium-term (2–4 yr)
Government home-care capacity-building programs +0.80% Asia-Pacific, South America Medium-term (2–4 yr)
Hospital cost-containment mandates shifting care to homes +0.70% Europe, North America Short-term (≤2 yr)
E-commerce and direct-to-consumer distribution expansion +0.55% Global Medium-term (2–4 yr)
Miniaturization and portability advances in device engineering +0.40% Global Long-term (≥4 yr)

 

Expanding Reimbursement Coverage

Public health frameworks shape durable medical equipment adoption through systemic policy adjustments. Government health programs continually update coverage guidelines to integrate advanced home-care modalities under Medicare Part B, which governs benefit categories for durable medical equipment, prosthetics, orthotics, and supplies. Regulatory authorities structure compliance benchmarks for medical devices, ensuring clinical safety and expanding access channels for home-based therapeutics across diverse patient populations and primary care infrastructure.

 

Aging Demographics and Chronic-Disease Burden

The UN projects that adults aged 65 and older will surpass 1.6 billion globally by 2035, up from 800 million in 2023 [9]. This demographic wave directly feeds demand across every segment of the Home Medical Equipment Market — from mobility aids and hospital beds to respiratory therapy units and insulin delivery systems. Diabetes alone affects over 537 million adults worldwide, and the International Diabetes Federation forecasts that figure will reach 643 million by 2030, making home-based glucose monitoring and insulin management the single largest therapeutic value pool [12].

Smart-Device Connectivity and Telehealth

Digital health integration combines connected home monitoring tools with remote clinical workflows to support chronic disease management. Healthcare systems leverage Bluetooth and cellular medical hardware to track physiological metrics continuously. Clinical evaluations indicate that structured remote patient monitoring programs help lower 30-day hospital readmission rates for vulnerable patient cohorts by up to 44%, aligning clinical outcomes with evolving outpatient reimbursement models and connected care standards

 

Government Home-Care Programs in Emerging Markets

Emerging economies are deploying national digital health missions to strengthen decentralized care delivery and upgrade primary health infrastructure. India's Ayushman Bharat Digital Mission operates with a centrally approved budget allocation of INR 1,600 crore to build foundational digital health infrastructure. These public procurement frameworks encourage multinational manufacturers to establish localized supply chains, lowering equipment costs and broadening patient access in developing healthcare markets.

 

 

Restraints Impact Analysis

Restraint ~% Impact on CAGR Geographic Relevance Impact Timeline
Complex and fragmented regulatory approvals –0.55% Global Long-term (≥4 yr)
Reimbursement rate compression and competitive bidding –0.45% North America Short-term (≤2 yr)
Supply-chain disruptions for critical components –0.35% Global Medium-term (2–4 yr)
Product liability and recall risks –0.25% North America, Europe Medium-term (2–4 yr)
Digital-literacy gaps among elderly end users –0.30% Asia-Pacific, MEA Long-term (≥4 yr)

 

Regulatory Fragmentation

Manufacturers operating across multiple jurisdictions must comply with distinct regulatory frameworks, including the U.S. FDA 510(k) pathway, the European Union Medical Device Regulation, China's NMPA, and Japan's PMDA. The European Commission notes that stringent regulatory transitions have created compliance backlogs, affecting thousands of legacy devices. Compliance costs for a mid-size home medical equipment manufacturer can exceed USD 2.5 million per device family.

 

Reimbursement Rate Compression

The Centers for Medicare & Medicaid Services implemented competitive bidding programs that reduced reimbursement rates for durable medical equipment by an average of 45% in designated bidding areas. While this procurement mechanism lowers outlays for public payers, it compresses profit margins for suppliers of hospital beds and oxygen equipment, driving industry consolidation and limiting manufacturer reinvestment in next-generation medical technologies.

 

Digital-Literacy Barriers

A Pew Research Center study reports that only 38% of U.S. adults aged 75 and older feel confident operating Bluetooth-enabled connected devices independently. In developing regions, digital literacy rates among elderly populations remain significantly lower, creating adoption constraints for smart healthcare tools. Supplemental training expenses for caregivers add USD 120 to 200 per patient quarterly, offsetting home-care savings.

 

Home Medical Equipment Market Opportunities

AI-Powered Predictive Health Platforms

Device manufacturers that integrate on-device machine-learning algorithms transform home equipment into proactive health monitors. Continuous glucose monitors with predictive alerts and smart dispensers represent high-margin adjacencies in the home medical market. The global artificial intelligence in healthcare market reaches USD 50 billion, and home devices sit at the data-generation edge of that expanding digital health ecosystem

 

Subscription and Equipment-as-a-Service Models

Shifting from one-time device sales to monthly subscription plans—bundling equipment, maintenance, and remote monitoring into a single fee—lowers upfront cost barriers for patients while generating recurring revenue for manufacturers. Major industry manufacturers have piloted subscription tiers for respiratory therapy that successfully reduced patient churn by up to 28% in early trials. This model supports high-consumable categories like diabetes management and wound care.

 

Emerging-Market Leapfrog via Mobile-First Distribution

In regions where traditional retail medical equipment infrastructure is sparse, mobile-commerce platforms bypass conventional distribution channels entirely. Digital health applications list home medical devices alongside pharmaceuticals, effectively reaching populations lacking proximity to specialized stores. Online distribution channels reflect a compound annual growth rate of 11.15% toward e-commerce accessibility, expanding medical equipment market penetration across emerging international populations.

 

Post-Acute Hospital-at-Home Programs

Hospital-at-home models, supported by clinical findings indicating a 19% lower mortality rate and 26% lower relative cost compared to traditional inpatient care for eligible acute conditions, require a full suite of home medical equipment ranging from infusion pumps to vital-sign monitors. As government healthcare authorities and commercial payers scale these acute care programs, device procurement volumes rise materially.

 

Data Monetization and Outcomes Analytics

Aggregated, de-identified data generated from connected home medical devices represents an expanding revenue opportunity. Pharmaceutical companies, insurers, and public health agencies utilize population-level adherence and disease-progression datasets that equipment manufacturers generate at scale. Privacy-compliant data partnerships provide an incremental 3% to 5% gross margin increase for manufacturers operating within the home medical equipment sector.

 

Home Medical Equipment Market Future Outlook

AI-Enabled Autonomous Home Diagnostics

By 2030, on-device AI will enable home medical equipment to perform screening-grade diagnostics without clinician intervention — think handheld ultrasound probes with automated image interpretation and ECG patches that flag arrhythmia subtypes in real time. The FDA's 2024 AI/ML Action Plan cleared a pathway for adaptive algorithms in home-use devices, and the European Commission's AI Act carves out a risk-proportionate framework that avoids blanket prohibition of autonomous diagnostics [22]. For the Home Medical Equipment Market, this trend transforms devices from data-capture endpoints into clinical-decision support tools.

Platform Economics and Interoperability

The next decade will reward manufacturers who build open-ecosystem platforms rather than walled-garden device families. Interoperability standards — HL7 FHIR for data exchange, IEEE 11073 for device communication — are maturing, and CMS has signaled that interoperability compliance will become a reimbursement prerequisite by 2028 [23]. Companies that position their devices as nodes within broader care platforms will capture a disproportionate share of the Home Medical Equipment Market.

Sustainability and Circular-Economy Models

E-waste regulations in the EU and extended-producer-responsibility mandates in Japan are pushing manufacturers toward modular device architectures that allow component-level repair and refurbishment. The circular economy for home medical devices — encompassing take-back programs, certified refurbishment, and recycled-material sourcing — could reduce lifecycle costs while satisfying ESG reporting requirements that institutional buyers increasingly demand [24].

Decentralized Clinical Trials and Home-Based Evidence Generation

Pharmaceutical sponsors are embedding connected home medical devices into decentralized clinical-trial protocols, using home-collected data to replace site visits. The Decentralized Trials & Research Alliance reported that 42% of new Phase III trials initiated in 2024 included at least one home-monitoring endpoint [25]. This trend positions the Home Medical Equipment Market as critical infrastructure for drug development, not just post-market care delivery.

 

Home Medical Equipment Market Segmentation

By Functionality

Segment Key Metric Primary Demand Driver
Therapeutic Equipment 48.50% revenue share (2025) Respiratory, infusion, and dialysis home therapy
Mobility Assist & Patient Support 9.25% CAGR (2026–2035) Aging population requiring walkers, wheelchairs, beds
Diagnostic & Monitoring Equipment USD 9.45 Billion (2025) Chronic-disease self-monitoring adoption

 

Therapeutic equipment remains the backbone of the Home Medical Equipment Market, driven by sustained demand for home oxygen therapy, nebulizers, infusion pumps, and peritoneal dialysis systems. Respiratory care devices alone account for a significant share of this category, buoyed by COPD prevalence that the WHO estimates affects 392 million adults globally [9]. Mobility assist and patient support are closing the gap through demographic momentum: powered wheelchair unit shipments grew 12% year-over-year in 2024, and hospital-bed rental services expanded into suburban and rural markets across North America and Europe.

By Therapeutic Area

Segment Key Metric Primary Demand Driver
Diabetes Care 42.15% revenue share (2025) CGM adoption, insulin pump penetration
Respiratory Care USD 11.20 Billion (2025) COPD, sleep apnea, home oxygen therapy
Cardiovascular 7.85% CAGR (2026–2035) Remote cardiac monitoring, heart failure management
Pain Management USD 3.10 Billion (2025) TENS units, home infusion for chronic pain
Others 8.40% revenue share (2025) Wound care, rehabilitation, nutrition

 

Diabetes care is the single largest therapeutic value pool in the Home Medical Equipment Market. Continuous glucose monitors (CGMs) from Dexcom and Abbott have crossed into mainstream consumer awareness, and insulin pump penetration rates in the U.S. reached 38% of Type 1 diabetes patients in 2024 [12]. Respiratory care holds the second-largest position, anchored by CPAP and BiPAP devices for obstructive sleep apnea — a condition that affects an estimated 936 million adults worldwide according to the Lancet Respiratory Medicine [13].

By Connectivity

Segment Key Metric Primary Demand Driver
Conventional Devices 57.90% revenue share (2025) Installed base, cost sensitivity in emerging markets
Connected / Smart Devices 10.55% CAGR (2026–2035) Telehealth integration, reimbursement incentives

 

Conventional devices still dominate by installed base, but the growth differential tells the story: connected devices are expanding nearly 60% faster in CAGR terms. The Home Medical Equipment Market is approaching an inflection point where connected devices will surpass conventional units in new-sales volume by the early 2030s, driven by payer mandates for remote monitoring and patient demand for app-based health tracking.

By Distribution Channel

Segment Key Metric Primary Demand Driver
Retail Medical Stores 42.65% revenue share (2025) In-person fitting, insurance billing infrastructure
Online Retailers 11.15% CAGR (2026–2035) Convenience, price transparency, direct-to-consumer
Direct Sales / Institutional USD 8.78 Billion (2025) Hospital-at-home programs, group purchasing

 

Retail Medical Stores captured a significant 42.65% revenue share in 2025 within the home medical equipment market. This traditional distribution channel thrives due to essential primary demand drivers, including specialized in-person equipment fitting services and established insurance billing infrastructure that supports patient purchasing needs.

Online Retailers represent a fast-growing distribution segment projected to expand at an 11.15% CAGR from 2026 to 2035. Driven by consumer demand for convenience, price transparency, and direct-to-consumer accessibility, this channel transforms how patients acquire essential home healthcare technologies.

Direct Sales and Institutional channels accounted for a baseline valuation of USD 8.78 billion in 2025. Growth across this sector is propelled by expanding hospital-at-home programs and institutional group purchasing organizations that streamline large-scale equipment deployment.

 

By End User

Segment Key Metric Primary Demand Driver
Elderly & Assisted-Living 36.80% revenue share (2025) Demographic aging, long-term mobility needs
Chronic-Disease Home-Care 9.65% CAGR (2026–2035) Diabetes, COPD, cardiovascular home management
Post-Surgical Recovery USD 6.15 Billion (2025) Early-discharge protocols, hospital-at-home

 

Elderly and Assisted-Living facilities represented the leading end-user segment, capturing 36.80% revenue share in 2025. Demand across this demographic is fueled by rapid population aging and long-term mobility needs requiring continuous home-care support.

 

Chronic-Disease Home-Care is projected to expand at a 9.65% CAGR from 2026 to 2035. This segment is heavily driven by the rising prevalence of chronic conditions like diabetes, chronic obstructive pulmonary disease, and cardiovascular management requiring ongoing home tracking. Post-Surgical Recovery end users accounted for a market valuation of USD 6.15 billion in 2025. Primary demand drivers for this segment include early-discharge clinical protocols and expanding hospital-at-home care initiatives.

 

Regional Market Share Analysis

Region Key Metric (2025) Primary Investment Themes
North America 40.35% market share Reimbursement optimization, connected-device integration
Europe 26.15% market share MDR compliance, aging-population demand
Asia-Pacific 9.45% CAGR (2026–2035) Government digitization, manufacturing localization
South America USD 3.14 Billion Private-sector hospital-at-home pilots
Middle East & Africa USD 2.82 Billion Public health infrastructure build-out
Total USD 54.20 Billion —

The Home Medical Equipment Market spans five major regions, each shaped by distinct regulatory architectures, demographic profiles, and distribution dynamics. North America and Europe together account for roughly two-thirds of global revenue, while Asia-Pacific is rapidly narrowing the gap.

 

North America

Country Key Metric Key Driver
United States 82.50% of regional share CMS reimbursement expansion, private-payer benefit tiers
Canada 10.80% of regional share Provincial home-care funding increases
Mexico 6.70% of regional share Growing private insurance penetration

 

The United States anchors the Home Medical Equipment Market in North America through its deep Medicare fee-for-service infrastructure and a network of over 12,000 accredited DME suppliers. Canada's provincial health authorities increased home-care budgets by an average of 9% in fiscal year 2024–2025, channeling procurement toward respiratory and mobility equipment [21]. Mexico's IMSS and ISSSTE public health systems have begun piloting home-oxygen and diabetes-management programs in metropolitan zones, opening an underpenetrated market for multinational OEMs.

Europe

Country Key Metric Key Driver
Germany 7.15% CAGR (2026–2035) SHI fund coverage for digital health devices
United Kingdom USD 2.35 Billion (2025) NHS integrated care system rollout
France 18.40% of regional share Télésurveillance reimbursement pathway
Italy 12.30% of regional share Aging demographics, regional health service reform
Spain USD 1.18 Billion (2025) Primary care decentralization
Nordic Countries 8.10% of regional share High digital-health adoption, welfare-state coverage
Russia 4.55% of regional share Import-substitution policy for medical devices
Rest of Europe 14.80% of regional share Varied regulatory alignment with EU MDR

 

Europe's Home Medical Equipment Market operates under the EU MDR framework, which raised post-market surveillance and clinical-evidence requirements significantly from 2021 onward. France's télésurveillance program, which reimburses connected-device-based remote monitoring for five chronic conditions, has become a model that Germany and Italy are adapting for their own payer systems [6].

Asia-Pacific

Country Key Metric Key Driver
China 34.20% of regional share Healthy China 2030 home-device targets
India 11.75% CAGR (2026–2035) Ayushman Bharat Digital Mission
Japan USD 2.68 Billion (2025) Super-aging society, robotics-aided care
South Korea 7.85% of regional share National Health Insurance Service expansion
ASEAN 9.90% CAGR (2026–2035) Mobile health platforms, rising middle class
Rest of Asia-Pacific 10.65% of regional share Varied public-health investment profiles

 

Asia-Pacific represents the highest-growth opportunity in the Home Medical Equipment Market. China's domestic manufacturers — Yuwell and Omron China — are scaling production of low-cost portable devices for tier-2 and tier-3 cities. At the same time, Japan's super-aging society (29.1% of the population above 65 in 2024) sustains premium-segment demand for robotic patient lifts and connected vital-sign monitors [5][7].

South America

Country Key Metric Key Driver
Brazil 58.30% of regional share SUS home-care program expansion
Argentina 22.15% of regional share Private-sector hospital-at-home pilots
Rest of South America 19.55% of regional share Growing chronic-disease prevalence

 

Brazil's Unified Health System (SUS) has gradually expanded home-care entitlements for post-surgical and chronic patients, making it the anchor market in South America for the Home Medical Equipment Market. Argentina's private health providers are piloting equipment-leasing models that lower capital barriers for middle-income households.

Middle East & Africa

Country Key Metric Key Driver
Saudi Arabia 28.40% of regional share Vision 2030 healthcare privatization
UAE 21.70% of regional share Medical tourism and premium home-care services
South Africa 18.90% of regional share Public-sector chronic-disease burden
Egypt 14.25% of regional share Population scale and NHI Act rollout
Rest of MEA 16.75% of regional share NGO-funded primary-care equipment programs

 

Saudi Arabia's Vision 2030 healthcare privatization agenda is driving hospital operators to launch premium home-care subsidiaries, creating demand for high-end therapeutic and monitoring equipment. The UAE's status as a medical-tourism hub extends into home-recovery services, where post-procedure patients are equipped with connected monitoring kits in the Home Medical Equipment Market before returning to their home countries.

 

Home Medical Equipment Market By Region, 2025-2035

Competitive Benchmarking

The Home Medical Equipment Market exhibits medium concentration. The top five players collectively hold an estimated 28–35% of global revenue, while a long tail of regional distributors, specialty OEMs, and contract manufacturers serves localized demand. M&A activity intensified between 2023 and 2025 as large medtech conglomerates acquired connected-device startups to accelerate their digital portfolios.

Company Est. Revenue Share Range Key Offerings for Home Medical Equipment Market Strategic Positioning
Medline Industries ~5–8% Wound care, incontinence, mobility aids Largest private U.S. distributor; vertically integrated manufacturing
Invacare Corporation ~4–7% Wheelchairs, respiratory products, home beds Global mobility-device specialist with European foothold
Philips Healthcare ~4–6% CPAP/BiPAP devices, patient monitors, ventilators Connected-health ecosystem strategy via HealthSuite platform
ResMed ~4–6% Sleep apnea devices, cloud-connected CPAP, SaaS SaaS-led recurring-revenue model; >15 million cloud-connected devices
Medtronic ~3–5% Insulin pumps, CGMs, cardiac monitors Deep clinical R&D pipeline; integrated diabetes management
Abbott Laboratories ~3–5% FreeStyle Libre CGM, diagnostic devices Consumer-facing CGM brand with OTC market penetration
Cardinal Health ~3–5% Distribution, home infusion services, supplies Supply-chain scale; pharmacy and distribution integration
Drive DeVilbiss Healthcare ~3–5% Wheelchairs, beds, respiratory devices Broad catalog across mobility and respiratory categories
Sunrise Medical ~2–4% Manual and powered wheelchairs, seating systems Premium wheelchair brand with custom-configuration capability
Baxter International ~2–4% Home dialysis systems, infusion therapy, nutrition Home-dialysis market leader; peritoneal dialysis focus

 

 

Recent News & Developments

 

  • Cardinal Health—(July 2026)--announced an agreement to acquire AdaptHealth's diabetes business and Strive Medical for approximately $360 million to expand its home medical solutions.
  • ResMed—(July 2026)--entered into an agreement to sell its MatrixCare business division to healthcare-focused private equity firm Frazier Healthcare Partners.
  • Endologix—(May 2026)--completed the acquisition of Surmodics' Pounce system, adding an FDA-cleared mechanical thrombectomy device for non-surgical removal of vascular emboli.

 

 

 

 

 

 

 

 

Home Medical Equipment Market Report Scope

Parameter Details
Market Scope Home Medical Equipment Market — therapeutic, diagnostic, mobility, and patient-support devices for non-clinical home use
Study Period 2021–2035
CAGR 6.65% (2026–2035)
Base Year Market Size USD 54.20 Billion (2025)
Forecast End-Point Market Size USD 103.18 Billion (2035)
Fastest Growing Segment Mobility Assist & Patient Support (by functionality); Connected/Smart Devices (by connectivity)
Companies Profiled 10 (Medline, Invacare, Philips, ResMed, Medtronic, Abbott, Cardinal Health, Drive DeVilbiss, Sunrise Medical, Baxter)
Valuation Currency USD Billion

 

 

FAQs

What reimbursement risks should investors monitor in the Home Medical Equipment Market?
CMS competitive-bidding resets scheduled for 2027 could compress DME payment rates by an additional 8–12% in new bidding areas [14]. Investors should track final rule announcements and state Medicaid waiver expansions that may offset federal rate pressure.
How does the EU MDR transition affect smaller device manufacturers?
Compliance costs per device family exceed USD 2.5 million, and notified-body capacity constraints have created 12–18-month approval backlogs [6]. Smaller OEMs increasingly pursue acquisition or licensing partnerships rather than self-certifying.
Which home medical devices are best suited for subscription pricing models?
High-consumable devices — CGMs, CPAP mask kits, wound-care supplies — convert most naturally to subscriptions because recurring supply needs create predictable revenue [19]. Equipment-as-a-service models work best when replacement cycles are under 90 days.
How do connected devices change the competitive dynamics in the Home Medical Equipment Market?
Connectivity shifts differentiation from hardware specifications to software ecosystems and data services. Manufacturers with proprietary cloud platforms capture higher lifetime value per patient than hardware-only competitors [3].
What role do group purchasing organizations play in this market?
GPOs aggregate procurement for long-term care facilities and home health agencies, negotiating volume discounts of 15–25% on standard equipment catalogs [10]. Their influence is strongest in North America for institutional-channel purchasing.
How will decentralized clinical trials influence home device demand in the Home Medical Equipment Market?
Pharma sponsors embedding home-collected endpoints into trial protocols create incremental demand for validated connected monitors [25]. This channel could represent 3–5% of total device volume by 2030.
What cybersecurity standards apply to connected home medical equipment?
The FDA's 2023 Refuse to Accept policy mandates cybersecurity documentation for all new connected-device submissions [22]. Manufacturers must demonstrate secure update mechanisms and vulnerability disclosure processes before clearance.    
Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, medical device registries, peer-reviewed clinical journals, and authoritative health technology organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), Centers for Medicare & Medicaid Services (CMS) HCPCS databases, European Medicines Agency (EMA) Medical Device Regulation (MDR) filings, Medical Device Single Audit Program (MDSAP) repositories, National Institutes of Health (NIH) National Library of Medicine, National Center for Biotechnology Information (NCBI/PubMed), CDC National Center for Health Statistics chronic disease surveillance, World Health Organization (WHO) Medical Device Information System, Eurostat Healthcare Database, US Census Bureau aging population demographics, Bureau of Labor Statistics occupational health data, Japan Ministry of Health Labour and Welfare Medical Device Division, Health Canada Medical Devices Directorate, and national home health ministry reports from key markets. These sources were used to collect device approval data (510(k) clearances, PMAs), procedure statistics for home dialysis and oxygen therapy, regulatory compliance metrics, reimbursement policy changes, chronic disease prevalence trends, and competitive landscape analysis for therapeutic equipment, patient monitoring systems, mobility aids, and respiratory devices.

 

Primary Research

To gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research phase. CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from HME manufacturers, such as manufacturers of respiratory therapy devices, continuous glucose monitoring system suppliers, OEMs of portable dialysis equipment, and manufacturers of mobility assist devices, were examples of supply-side sources. Directors of home health agencies, providers of durable medical equipment (DME), procurement leads from hospital-at-home programs, managers of rehabilitation facilities, clinical engineers, and reimbursement specialists from Medicare Advantage plans and commercial insurers were examples of demand-side sources. Primary research confirmed product pipeline timelines for connected home devices, validated market segmentation across therapeutic and monitoring categories, and obtained information on CMS competitive bidding dynamics, rental vs. purchase pricing models, and clinical adoption patterns of remote patient monitoring technologies.

Primary Respondent Breakdown:

By Designation: C-level Primaries (30%), Director Level (35%), Others (35%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping, procedure volume analysis, and Medicare claims data assessment. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in home respiratory devices, infusion systems, patient monitoring wearables, and mobility solutions

Product mapping across therapeutic equipment (oxygen concentrators, CPAP/BiPAP systems, home dialysis units, infusion pumps), patient monitoring equipment (continuous glucose monitors, pulse oximeters, blood pressure monitors, ECG home systems), and mobility assist & patient support equipment (wheelchairs, patient lifts, bathroom safety devices)

Analysis of reported and modeled annual revenues specific to HME portfolios, including rental revenue streams and direct-to-consumer sales channels

Coverage of manufacturers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (device unit volume × ASP by country, procedure volumes for home dialysis and oxygen therapy) and top-down (manufacturer revenue validation against CMS expenditure data) approaches to derive segment-specific valuations for therapeutic, monitoring, and mobility equipment categories

Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.